{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:55:04Z","timestamp":1794956104900,"version":"4.9.1"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"45","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The value of elective coronary revascularisation plus medical therapy over medical therapy alone in managing stable patients with coronary artery disease is debated. We reviewed all trials comparing the two strategies in this population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>From inception through November 2020, MEDLINE, EMBASE, Google Scholar, and other databases were searched for randomised trials comparing revascularisation against medical therapy alone in clinically stable coronary artery disease patients. Treatment effects were measured by rate ratios (RRs) with 95% confidence intervals, using random-effects models. Cardiac mortality was the pre-specified primary endpoint. Spontaneous myocardial infarction (MI) and its association with cardiac mortality were secondary endpoints. Further endpoints included all-cause mortality, any MI, and stroke. Longest follow-up data were abstracted. The study is registered with PROSPERO (CRD42021225598). Twenty-five trials involving 19\u00a0806 patients (10\u00a0023 randomised to revascularisation plus medical therapy and 9783 to medical therapy alone) were included. Compared with medical therapy alone, revascularisation yielded a lower risk of cardiac death [RR 0.79 (0.67\u20130.93), P\u2009&amp;lt;\u20090.01] and spontaneous MI [RR 0.74 (0.64\u20130.86), P\u2009&amp;lt;\u20090.01]. By meta-regression, the cardiac death risk reduction after revascularisation, compared with medical therapy alone, was linearly associated with follow-up duration [RR per 4-year follow-up: 0.81 (0.69\u20130.96), P\u2009=\u20090.008], spontaneous MI absolute difference (P\u2009=\u20090.01) and percentage of multivessel disease at baseline (P\u2009=\u20090.004). Trial sequential and sensitivity analyses confirmed the reliability of the cardiac mortality findings. All-cause mortality [0.94 (0.87\u20131.01), P\u2009=\u20090.11], any MI (P\u2009=\u20090.14), and stroke risk (P\u2009=\u20090.30) did not differ significantly between strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In stable coronary artery disease patients, randomisation to elective coronary revascularisation plus medical therapy led to reduced cardiac mortality compared with medical therapy alone. The cardiac survival benefit after revascularisation improved with longer follow-up times and was associated with fewer spontaneous MIs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab246","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T11:08:54Z","timestamp":1618312134000},"page":"4638-4651","source":"Crossref","is-referenced-by-count":145,"title":["Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"42","author":[{"given":"Eliano P","family":"Navarese","sequence":"first","affiliation":[{"name":"Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University , Bydgoszcz, Poland"},{"name":"Faculty of Medicine, University of Alberta , Edmonton, Canada"},{"name":"SIRIO MEDICINE research network , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J","family":"Lansky","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine , New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J","family":"Kereiakes","sequence":"additional","affiliation":[{"name":"Christ Hospital and Lindner Research Center , Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kubica","sequence":"additional","affiliation":[{"name":"Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University , Bydgoszcz, Poland"},{"name":"SIRIO MEDICINE research network , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Gurbel","sequence":"additional","affiliation":[{"name":"Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore , Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A","family":"Gorog","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Heart and Lung Institute, Imperial College , London, UK"},{"name":"Cardiology Department, East and North Hertfordshire NHS Trust , Stevenage, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital Universit\u00e4tsspital , Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Curzen","sequence":"additional","affiliation":[{"name":"University Hospital Southampton NHS Foundation Trust, Southampton , UK"},{"name":"University of Southampton , Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E","family":"Kandzari","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Piedmont Heart Institute , Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P","family":"Bonaca","sequence":"additional","affiliation":[{"name":"CPC Clinical Research, University of Colorado School of Medicine , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brouwer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Centre , Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Umi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Nicolaus Copernicus University , Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milosz J","family":"Jaguszewski","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Gdansk , Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Raggi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Alberta , Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[{"name":"Section of Interventional Cardiology, MedStar Washington Hospital Center , Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B","family":"Leon","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Columbia University Irving Medical Center , New York, NY, USA"},{"name":"Cardiovascular Research Foundation, New York , NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[{"name":"The Lambe Institute for Translational Medicine and Curam, National University of Ireland Galway and Saolta University Healthcare Group , Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Andreotti","sequence":"additional","affiliation":[{"name":"Direzione Scientifica, Fondazione Policlinico Universitario Gemelli IRCCS , Rome, Italy"},{"name":"Cardiovascular Medicine, Catholic University Medical School , Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"2022102514442059600_ehab246-B1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"2022102514442059600_ehab246-B2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102514442059600_ehab246-B3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102514442059600_ehab246-B4","doi-asserted-by":"crossref","first-page":"e003255","DOI":"10.1161\/CIRCHEARTFAILURE.116.003255","article-title":"Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis","volume":"10","author":"Wolff","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2022102514442059600_ehab246-B5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B7","author":"Higgins","year":"2020"},{"key":"2022102514442059600_ehab246-B8","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2022102514442059600_ehab246-B9","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"ISCHEMIA CKD Research Group Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B10","volume-title":"J Am Coll Cardiol","author":"Werner"},{"key":"2022102514442059600_ehab246-B11","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/eurheartj\/ehy223","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document","volume":"39","author":"Garcia-Garcia","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102514442059600_ehab246-B12","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2018.2525","article-title":"Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis","volume":"319","author":"Navarese","year":"2018","journal-title":"JAMA"},{"key":"2022102514442059600_ehab246-B13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2022102514442059600_ehab246-B14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0197-2456(86)90034-6","article-title":"Analysis of data from multiclinic trials","volume":"7","author":"Fleiss","year":"1986","journal-title":"Control Clin Trials"},{"key":"2022102514442059600_ehab246-B15","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"key":"2022102514442059600_ehab246-B16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2022102514442059600_ehab246-B17","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.297.18.1985","article-title":"Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial","volume":"297","author":"Erne","year":"2007","journal-title":"JAMA"},{"key":"2022102514442059600_ehab246-B18","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.jacc.2006.07.068","article-title":"An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction","volume":"48","author":"Mahmarian","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B19","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","article-title":"Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B20","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jcin.2018.05.041","article-title":"A randomized trial to assess regional left ventricular function after stent implantation in chronic total occlusion: the REVASC trial","volume":"11","author":"Mashayekhi","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102514442059600_ehab246-B21","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction","volume":"120","author":"Chaitman","year":"2009","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B23","doi-asserted-by":"crossref","first-page":"II107","DOI":"10.1161\/circ.100.suppl_2.Ii-107","article-title":"Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis","volume":"100","author":"Hueb","year":"1999","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-9149(79)80190-3","article-title":"Long term follow-up (4-7 years) of a prospective randomized study to evaluate surgical vs medical treatment for stable angina pectoris: clinical status, exercise performance and survival [abstract]","volume":"43","author":"Mathur","year":"1979","journal-title":"Am J Cardiol"},{"key":"2022102514442059600_ehab246-B25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM198808113190603","article-title":"Twelve-year follow-up of survival in the randomized European Coronary Surgery Study","volume":"319","author":"Varnauskas","year":"1988","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B26","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/01.CIR.95.8.2037","article-title":"Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization","volume":"95","author":"Davies","year":"1997","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B27","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0735-1097(97)00097-1","article-title":"Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME Investigators","volume":"29","author":"Folland","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199201023260102","article-title":"A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators","volume":"326","author":"Parisi","year":"1992","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B30","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B31","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/01.CIR.82.5.1629","article-title":"Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study","volume":"82","author":"Alderman","year":"1990","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.68.5.939","article-title":"CASS Principal Investigators and their Associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Survival data","volume":"68","year":"1983","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B34","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","article-title":"Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial","volume":"36","author":"Zimmermann","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102514442059600_ehab246-B35","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/01.CIR.103.24.2928","article-title":"Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial","volume":"103","author":"Bech","year":"2001","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B36","first-page":"1173","article-title":"European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris.","volume":"2","year":"1982","journal-title":"Lancet"},{"key":"2022102514442059600_ehab246-B37","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102514442059600_ehab246-B38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcin.2008.08.002","article-title":"Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease: a randomized, comparative, multicenter study","volume":"1","author":"Nishigaki","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102514442059600_ehab246-B40","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/0735-1097(95)00384-3","article-title":"The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses","volume":"26","author":"Hueb","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B41","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2003.08.065","article-title":"The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results","volume":"43","author":"Hueb","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0003-4975(10)64469-4","article-title":"Surgical versus medical treatment for stable angina pectoris: prospective randomized study with 1- to 4-year follow-up","volume":"22","author":"Guinn","year":"1976","journal-title":"Ann Thorac Surg"},{"key":"2022102514442059600_ehab246-B43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"2022102514442059600_ehab246-B44","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0735-1097(03)00951-3","article-title":"Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy","volume":"42","author":"Henderson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","article-title":"RITA-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"2022102514442059600_ehab246-B46","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/01.CIR.0000140983.69571.BA","article-title":"Trial of Invasive versus Medical therapy in Elderly patients Investigators. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME)","volume":"110","author":"Pfisterer","year":"2004","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(01)06100-1","article-title":"TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"2022102514442059600_ehab246-B48","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9149(98)00204-5","article-title":"Twenty-two-year follow-up in the VA Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina","volume":"81","author":"Peduzzi","year":"1998","journal-title":"Am J Cardiol"},{"key":"2022102514442059600_ehab246-B49","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM198411223112102","article-title":"Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"key":"2022102514442059600_ehab246-B50","doi-asserted-by":"crossref","first-page":"e007008","DOI":"10.1161\/CIRCINTERVENTIONS.118.007008","article-title":"Mortality after percutaneous coronary intervention: narrowing the knowledge gap","volume":"11","author":"Cutlip","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102514442059600_ehab246-B51","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.120.047987","article-title":"Infarction in the ISCHEMIA trial: impact of different definitions on incidence, prognosis, and treatment comparisons","volume":"143","author":"Chaitman","year":"2021","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B52","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jacc.2020.07.002","article-title":"Limitations of long-term mortality as a clinical trial endpoint: time wounds all healing","volume":"76","author":"Seto","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B53","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jacc.2020.09.536","article-title":"Influence of LDL-cholesterol lowering on cardiovascular outcomes in patients with diabetes mellitus undergoing coronary revascularization","volume":"76","author":"Farkouh","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B54","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jacc.2020.09.576","article-title":"Long-term outcomes following coronary revascularizations in diabetes mellitus: the emerging role of LDL-C thresholds","volume":"76","author":"Navarese","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102514442059600_ehab246-B55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.120.048194","article-title":"Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials","volume":"142","author":"Bangalore","year":"2020","journal-title":"Circulation"},{"key":"2022102514442059600_ehab246-B56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0003-4975(10)66846-4","article-title":"Effect of crossover on the statistical power of randomized studies","volume":"48","author":"Weinstein","year":"1989","journal-title":"Ann Thorac Surg"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/45\/4638\/46624213\/ehab246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/45\/4638\/46624213\/ehab246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T17:25:22Z","timestamp":1666718722000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/45\/4638\/6276780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":56,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2021,5,18]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab246","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,5,18]]}}}